|
Results are in from two pioneering studies conducted by researchers at Duke University Medical Center. The news is encouraging for people with glioblastoma multiforme (GBM), one of the more common and deadliest types of brain tumors. Both studies involve the use of vaccines, in conjunction with chemotherapy, to try to boost the body’s immune response to the cancers. Preliminary results were presented in late May at the American Society of Clinical Oncology’s annual meeting in Chicago. For the full news story, please click here.
|
|
|
|
This information is for informational purposes only. This information is not a substitute for professional medical advice. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition. Use of this online service is subject to the disclaimer and the terms and conditions. Copyright 2008 © American Cancer Society |
|
|